Results 81 to 90 of about 1,163 (152)

Deprescribing: An umbrella review

Acta Pharmaceutica
This umbrella review examined systematic reviews of deprescribing studies by characteristics of intervention, population, medicine, and setting. Clinical and humanistic outcomes, barriers and facilitators, and tools for deprescribing are presented.
Japelj Nuša, Horvat Nejc, Knez Lea, Kos Mitja   +3 more
doaj   +1 more source

'Recommendations for deprescribing of medication in the last phase of life: an international Delphi study'. [PDF]

CONTEXT Medications may become inappropriate for patients in the last phase of life and may even compromise their quality of life. OBJECTIVE To find consensus on recommendations regarding deprescribing of medications for adult patients with a ...
Elsten, E E C M, Eychmüller, S, Fürst, C J, Geijteman, E C T, Hedman, C, Pot, I E, van der Heide, A, van der Kuy, H, van der Rijt, C C D, van Zuylen, L   +9 more
core   +2 more sources

Co‐Creation Study Protocol for Developing a Nurse‐Led Intervention to Deprescribe Benzodiazepines and Z‐Hypnotics in Primary Care Aimed at Empowering Women

Health Expectations, Volume 28, Issue 5, October 2025.
Visual Abstract ABSTRACT Background Gender inequality in mental health is a persistent challenge that requires innovative solutions for its resolution. Interventions in primary care can be useful in narrowing the gap in the consumption of psychotropic drugs.
Amaia Cuesta‐Zigorraga, Carlota Las Hayas Rodríguez   +1 more
wiley   +1 more source

Identification of Barriers and Needs in the Discontinuation of Benzodiazepine Receptor Agonists in Elderly Patients of a Rural Community—A Qualitative Study

Geriatrics
Background/Objectives: The predictors of successful discontinuation of benzodiazepine agonist receptors (BZRA) in elderly patients are not well known due to lack of research on the subject, and there is a need for further investigation, with more focus ...
Tiago de Barros Mendes, Marta Nazha, Ana Luísa Neves, Paula Broeiro-Gonçalves   +3 more
doaj   +1 more source

Polifarmácia, interações medicamentosas e iatrogenia: Um estudo sobre desafios terapêuticos em indivíduos idosos [PDF]

This study aimed to comprehensively address therapeutic challenges in medication use among the elderly. The research utilized the Medication Use Instrument within the Falls Risk Assessment Battery (BARQ) to collect and analyze data on medication ...
Andrade Dantas, Karollyni Bastos, Andrade Dantas, Karollyni Bastos, Andrade Dantas, Karollyni Bastos, da Silva Cursino Ribeiro, Maria Eduarda, da Silva Cursino Ribeiro, Maria Eduarda, da Silva Cursino Ribeiro, Maria Eduarda, de Assis, Gabriella Lucas, de Assis, Gabriella Lucas, de Assis, Gabriella Lucas, Gomes Ribeiro da Costa, Lúcio Flávio, Gomes Ribeiro da Costa, Lúcio Flávio, Gomes Ribeiro da Costa, Lúcio Flávio, Martin Dantas, Estélio Henrique, Martin Dantas, Estélio Henrique, Martin Dantas, Estélio Henrique, Rosa, Cássia Fernanda, Rosa, Cássia Fernanda, Rosa, Cássia Fernanda, Santana Goes, Aline, Santana Goes, Aline, Santana Goes, Aline, Santos Lima, Vitória, Santos Lima, Vitória, Santos Lima, Vitória, Souza Nascimento Melo, Ana Lúcia, Souza Nascimento Melo, Ana Lúcia, Souza Nascimento Melo, Ana Lúcia   +26 more
core   +2 more sources

Beliefs and attitudes about deprescription in older HIV-infected patients: ICARD Project.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2020
HIV population is aging at an earlier age than those uninfected, requiring more non-HIV medications to treat noncommunicable diseases. In the context of chronic HIV infection, the next therapeutic change would be the polymedication control. This paper has the purpose of explore the attitudes of older people living with HIV toward deprescribing.This was
Serrano Giménez, R, Gallardo Anciano, J, Robustillo Cortés, M A, Blanco Ramos, J R, Gutiérrez Pizarraya, A, Morillo Verdugo, R   +5 more
openaire   +3 more sources

Development of a Deprescribing Intervention for Proton Pump Inhibitors in Primary Care: A Co‐Design Approach With General Practitioners and Patients

Basic &Clinical Pharmacology &Toxicology, Volume 137, Issue 3, September 2025.
ABSTRACT Proton Pump Inhibitors (PPIs) are widely prescribed medications globally. PPIs are often inappropriately used – for example, prescribed without a clear indication, at higher‐than‐necessary doses, or for longer durations than needed – resulting in increased risks of adverse health outcomes such as nutrient deficiencies, osteoporosis‐related ...
Kristie Rebecca Weir, Clémentine Tombez, Yvonne Mattmann, Sofia C. Zambrano, Eliza Ferguson, Katharina Tabea Jungo, Martina Zangger, Shana Volken, Enriqueta Vallejo‐Yagüe, Renata Vidonscky Lüthold, Angela Edith Schulthess‐Lisibach, Christof Bieri, Michaela Barbier, Pascal Juillerat, Sven Streit, Jennifer Inauen   +15 more
wiley   +1 more source

Deprescribing Benzodiazepine Receptor Agonists in Older Adults and People With Cognitive Impairment: A Systematic Review

Journal of the American Geriatrics Society, Volume 73, Issue 9, Page 2905-2913, September 2025.
ABSTRACT Background Benzodiazepine receptor agonists (BZRAs) (benzodiazepines and z‐drugs) may provide limited benefits in the management of insomnia when used short‐term. However, they increase the risk of harms including falls, fractures, hospitalizations, and cognitive impairment. Deprescribing (cessation) of BZRAs may be beneficial for older adults
Aisling M. McEvoy, Aili V. Langford, Shin J. Liau, Darshna Goordeen, Emily Reeve, Justin P. Turner   +5 more
wiley   +1 more source

Deprescribing: a self-portrait about the reduction of polypharmacy in Portugal [PDF]

, 2020
Drug use in older adults’ patients (≥65 years) is extensive, increases substantially with age, and is associated with many adverse outcomes. Polypharmacy is commonly defined as taking 5 or more medications daily and affects between 30 and 70% of older ...
Simões, Pedro Augusto Gomes Rodrigues Marques
core  

Deprescription

, 2019
---
Sgnaolin, Vanessa, Engroff, Paula
openaire   +1 more source